Infantile Hemangiomas: Classification and Beta-Blocker Treatment
Infantile hemangiomas are the most common benign vascular tumors in infants, characterized by a proliferation of endothelial cells. They typically undergo a growth phase followed by gradual involution, and beta-blockers, particularly propranolol, have emerged as a standard treatment for their management.
Topics: hemangioma, propranolol, infantile
Overview / Definition Infantile hemangiomas (IH) are benign vascular tumors that arise from the proliferation of endothelial cells. They most commonly present in infancy and are characterized by a rapid growth phase followed by spontaneous involution over several years. These lesions can be superficial, deep, or mixed, and their management varies based on their size, location, and associated complications. Epidemiology Infantile hemangiomas are the most common tumors of infancy, occurring in approximately 4-5% of newborns. They are more prevalent in: Females (3:1 ratio compared to males) Premature infants Infants with low birth weight Pathophysiology / Mechanism The pathogenesis of infantile hemangiomas is not entirely understood, but it involves a complex interplay of factors: Endothelial cell proliferation Increased angiogenesis due to hypoxia Involvement of placental factors and vascular endothelial growth factor (VEGF) During the proliferative phase, there is a marked increase in endothelial cells, followed by apoptosis and regression during the involution phase. Clinical Presentation Infantile hemangiomas can be classified into three main types based on their morphology: Superficial hemangiomas: Often appear as bright red, raised lesions on the skin's surface (strawberry hemangiomas). Deep hemangiomas: Present as bluish, soft masses beneath the skin. Mixed hemangiomas: Exhibit characteristics of both superficial and deep types. These lesions typically appear within the first few weeks of life, and their growth usually peaks by 6-12 months. Complications may arise, including: Ulceration Bleeding Functional impairment depending on location (e.g., periorbital hemangiomas affecting vision) Diagnosis / Workup The diagnosis of infantile hemangiomas is primarily clinical, based on characteristic appearance and growth patterns. However, in certain cases, imaging may be required: Ultrasound: Useful for evaluating deep hemangiomas and assessing for complications. MRI: Co